David MacDonald
Technik-/Wissenschafts-/F&E-Leiter bei XORTX THERAPEUTICS INC.
Ursprung des Netzwerks ersten Grades von David MacDonald
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 15 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von David MacDonald
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| QUINCY ENERGY CORP. | Other Metals/Minerals | Director of Finance/CFO | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MICROBIX BIOSYSTEMS INC. | Biotechnology | Director/Board Member | |
| TALISKER RESOURCES LTD. | Precious Metals | Director/Board Member Corporate Secretary | |
| WINDFALL GEOTEK INC. | Precious Metals | Director/Board Member | |
| CGX ENERGY INC. | Oil & Gas Production | Director of Finance/CFO Public Communications Contact | |
| CARDIOCOMM SOLUTIONS, INC. | Packaged Software | Director/Board Member | |
| GRANDE PORTAGE RESOURCES LTD. | Precious Metals | Chief Executive Officer | |
Zacoro Metals Corp.
 Zacoro Metals Corp. Precious MetalsNon-Energy Minerals Zacoro Metals Corp. mines and explores for gold and other metals. It engages in the mining of copper, gold, and zinc. The company is located in Toronto, Canada | Precious Metals | Director of Finance/CFO Corporate Secretary | |
| GMV MINERALS INC. | Precious Metals | Chief Executive Officer | |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Pharmaceuticals: Major | Director/Board Member | |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Pharmaceuticals: Major | Compliance Officer | |
| PROMIS NEUROSCIENCES, INC. | Biotechnology | Director/Board Member | |
| University of Laurentian | College/University | Undergraduate Degree | |
| FORRESTER METALS INC | Other Metals/Minerals | Director/Board Member Investor Relations Contact | |
| University of Ottawa | College/University | Masters Business Admin | |
| Rensselaer Polytechnic Institute | College/University | Masters Business Admin | |
| University of Toronto | College/University | Undergraduate Degree Graduate Degree | |
| University of Western Ontario | College/University | Undergraduate Degree Undergraduate Degree | |
| McMaster University | College/University | Undergraduate Degree | |
Trelawney Mining & Exploration, Inc.
 Trelawney Mining & Exploration, Inc. Precious MetalsNon-Energy Minerals Trelawney Mining & Exploration, Inc. mines for gold and other miscellaneous minerals. The firm's current focus is the exploration and development of the Côté Lake Gold Deposit in the Swayze Greenstone Belt, located halfway between Timmins and Sudbury. The company was founded on July 4, 1996 and is headquartered in Toronto, Canada. | Precious Metals | Director/Board Member Corporate Secretary | |
Purdue Pharma (Canada)
 Purdue Pharma (Canada) Pharmaceuticals: MajorHealth Technology Purdue Pharma (Canada) manufactures and markets pharmaceutical products. It products for the treatment of pain, respiratory disease, gastrointestinal disorders, and infection control. The firm include laxatives, bronchodilators, antiseptics, and analgesics. Purdue Pharma is headquartered in Pickering, Canada | Pharmaceuticals: Major | Compliance Officer | |
| Institute of Chartered Accountants of Alberta | Corporate Officer/Principal | ||
Institute of Corporate Directors
 Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Eisai Medical Research, Inc. | Chief Tech/Sci/R&D Officer | ||
| TITAN MEDICAL INC. | Medical Specialties | Director/Board Member | |
| SECURE ENERGY SERVICES INC. | Environmental Services | Comptroller/Controller/Auditor | |
Toronto Innovation Acceleration Partners
 Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
| SOUTH STAR BATTERY METALS CORP. | Metal Fabrication | Director/Board Member | |
Kalgene Pharmaceuticals, Inc.
 Kalgene Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Kalgene Pharmaceuticals, Inc. develops and focuses on personalized cancer diagnostics and drugs. It offers drugs for epithelial and thyroid cancers. The firm's oncology programs are aimed at improving clinical and survival outcomes through the use of personalized medicine, with a particular focus on bladder, epithelial and thyroid cancers. It serves the biopharmaceutical, research and development and health industries. The company is headquartered in Kingston, Canada. | Medical/Nursing Services | Chairman | |
Canabo Medical Corp.
 Canabo Medical Corp. Pharmaceuticals: MajorHealth Technology Canabo Medical Corp. conducts scientific and medical research services through its network of healthcare practitioners at medical clinics. It specializes in patient care in the field of prescription cannabinoids and medical marijuana. The firm's referral-only clinics incorporate evidence-based medicine in combination with expert opinion to treating the needs of patients suffering from chronic and disabling illnesses to improve their quality of life. The company is headquartered in Vancouver, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| G6 MATERIALS CORP. | Chemicals: Major Diversified | President | |
XORTX Pharma Corp.
 XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Sunovion CNS Development Canada Ulc
 Sunovion CNS Development Canada Ulc Pharmaceuticals: MajorHealth Technology Sunovion CNS Development Canada Ulc develops pharmaceuticals products. The company is headquartered in Vancouver, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
| SIXTY NORTH GOLD MINING LTD. | Precious Metals | Director/Board Member | |
| EXEBLOCK TECHNOLOGY CORPORATION | Packaged Software | Chief Executive Officer | |
| POND TECHNOLOGIES HOLDINGS INC. | Pharmaceuticals: Other | Director/Board Member | |
| ALEAFIA HEALTH INC. | Agricultural Commodities/Milling | Director/Board Member | |
| TRANSCANNA HOLDINGS INC. | Agricultural Commodities/Milling | Director/Board Member | |
Nanjing Levena Biopharma Co. Ltd.
 Nanjing Levena Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Sorrento Therapeutics, Inc., Nanjing Levena Biopharma Co. Ltd. manufactures and supplies biopharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Valo Therapeutics Oy
 Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
| Next Level Consultants, Inc. | President |
Statistik
International
| Kanada | 40 |
| Vereinigte Staaten | 9 |
| Irland | 2 |
| China | 2 |
| Finnland | 2 |
Sektoral
| Health Technology | 20 |
| Non-Energy Minerals | 11 |
| Consumer Services | 7 |
| Process Industries | 4 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 61 |
| Director of Finance/CFO | 41 |
| Corporate Officer/Principal | 29 |
| Independent Dir/Board Member | 25 |
| President | 20 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jim Fairbairn | 45 |
| Paul van Damme | 26 |
| Anthony Giovinazzo | 22 |
| Ian Klassen | 15 |
| Charlotte May | 11 |
| Raymond Pratt | 11 |
| Patrick Treanor | 10 |
| Jacqueline Le Saux | 9 |
| William Farley | 8 |
| Stephen Haworth | 6 |
| Allen Davidoff | 5 |
| Amar Keshri | 5 |
| Brian Mangal | 4 |
| Stacy Evans | 3 |
| Nick Rigopulos | 1 |
- Börse
- Insiders
- David MacDonald
- Unternehmensverbindungen
